Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Jul 1;15(9):e1. doi: 10.14309/ctg.0000000000000743

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology

This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

PMC Copyright notice

Figure 2. — (a) VIP for neuromodulator and/or prokinetics. The most important variables were delayed GES, no diabetes, and BMI, followed by infectious prodrome. Break down plots for subjects with (b) high and (c) low predicted probability for response to neuromodulators and/or prokinetics. The intercept represents the mean model-specific predicted probability for response to neuromodulators and/or prokinetics while each subsequent variable increases (green bar) or decreases (red bar) the predicted probability and results in the overall predicted probability (purple bar, labeled prediction). BMI, body mass index; GES, gastric emptying scintigraphy; id, idiopathic; VIP, variable importance plot.